ARCHIVES

Clanton Resigns From NCI.

This article is from The Cancer Letter archive.

Vol. 33 No. 01 | January 12, 2007

Download PDF Visit The Full Archive

Related Articles

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

December 27, 2013

Novel Compounds Alone Or Combined With Chemo Tested In Blood Cancers

January 26, 2007

In Brief: NCAB Appointments: Boutwell Stay On; Brown, Elion, Strong, Korn Named; One Vacancy Remains

May 18, 1984

Avon Gives $3 Million To Expand CDC’s Screening Program

February 18, 1994

NCI CTEP Approved Trials For the Month of January

January 31, 2014

New Regimens May Benefit Multiple Myeloma Patients

January 28, 2005